Skip to main content

Advertisement

Log in

Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Hepatitis B virus (HBV) is one of the most prevalent chronic viral infections that causes chronic hepatitis B (CHB). In Japan, genotypes B and C account for most of acute and chronic cases of hepatitis. However, previous studies showed that the prevalence of genotype A in CHB gradually increased every 5 years. Therefore, we have conducted a nationwide survey to comprehensively investigate the trends of HBV genotype distribution in CHB patients in Japan.

Methods

4421 CHB patients were recruited between 2015 and 2016. Clinical characteristics and distribution of CHB patients among different age groups and genotypes in 2015–2016 was compared with those in 2000–2001, 2005–2006, and 2010–2011.

Results

The percentages of genotype A, B, C, and D were 4.0, 16.2, 79.1, and 0.7%, respectively. While the overall percentage of CHB patients with genotype A did not change in the past 5 years, CHB with genotype A increased in young adults. On the other hand, the peak distribution of CHB with genotypes B and C, two genotypes with the largest patient population, has shifted to an older age group.

Conclusions

In Japan, the peak distribution for CHB with genotypes B and C advanced to an older age group while CHB with genotype A expanded in a younger age group. Given the universal HBV vaccination launch in Japan in 2016, these pre-vaccination survey data provide important baseline information for comparative studies of the impact of universal vaccination on HBV genotypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

HBV:

Hepatitis B virus

HBsAg:

Hepatitis B surface antigen

AHB:

Acute hepatitis B

HBeAg:

Hepatitis B-e antigen

CHB:

Chronic hepatitis B

HCC:

Hepatocellular carcinoma

CT:

Computerized tomography

MRI:

Magnetic resonance imaging

EIA:

Enzyme immunoassay

HIV:

Human immunodeficiency virus

References

  1. Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol. 1988;69:2575–83.

    Article  CAS  PubMed  Google Scholar 

  2. Norder H, Hammas B, Lofdahl S, et al. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol. 1992;73:1201–8.

    Article  CAS  PubMed  Google Scholar 

  3. Orito E, Ichida T, Sakugawa H, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology. 2001;34:590–4.

    Article  CAS  PubMed  Google Scholar 

  4. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology. 2003;46:329–38.

    Article  CAS  PubMed  Google Scholar 

  5. Norder H, Couroucé AM, Coursaget P, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004;47:289–309.

    Article  PubMed  Google Scholar 

  6. Kurbanov F, Tanaka Y, Mizokami M. Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res. 2010;40:14–30.

    Article  PubMed  Google Scholar 

  7. Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol. 2002;17:643–50.

    Article  CAS  PubMed  Google Scholar 

  8. Suzuki Y, Kobayashi M, Ikeda K, et al. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan. J Med Virol. 2005;76:33–9.

    Article  PubMed  Google Scholar 

  9. Ito K, Yotsuyanagi H, Sugiyama M, et al. Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan. J Gastroenterol Hepatol. 2016;31:180–9.

    Article  PubMed  Google Scholar 

  10. Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59:89–97.

    Article  CAS  PubMed  Google Scholar 

  11. Ito K, Yoneda M, Sakamoto K, et al. Virological and clinical characteristics of hepatitis B virus genotype A. J Gastroenterol. 2018;53:18–26.

    Article  CAS  PubMed  Google Scholar 

  12. Sugiyama M, Tanaka Y, Kato T, et al. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology. 2006;44:915–24.

    Article  CAS  PubMed  Google Scholar 

  13. Ito K, Kim KH, Lok AS, et al. Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme. J Virol. 2009;83:3507–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Progress in hepatitis B prevention through universal infant vaccination--China, 1997–2006. MMWR Morbidity and mortality weekly report. 2007;56:441–5.

  15. Matsuura K, Tanaka Y, Hige S, et al. Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol. 2009;47:1476–83.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Usuda S, Okamoto H, Iwanari H, et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods. 1999;80:97–112.

    Article  CAS  PubMed  Google Scholar 

  17. Ito K, Tanaka Y, Kato M, et al. Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion. J Gastroenterol. 2007;42:837–44.

    Article  CAS  PubMed  Google Scholar 

  18. Horai S, Murayama K, Hayasaka K, et al. mtDNA polymorphism in East Asian populations, with special reference to the peopling of Japan. Am J Hum Genet. 1996;59:579–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Michitaka K, Tanaka Y, Horiike N, et al. Tracing the history of hepatitis B virus genotype D in western Japan. J Med Virol. 2006;78:44–52.

    Article  PubMed  Google Scholar 

  20. Ito K. Trends and molecular biological analysis of hepatitis B virus genotype distribution (Japanese). Research result report for Grants-in Aid for Scientific Research. 2018:1–5.

  21. Shiraki K. Vertical Transmission of Hepatitis B Virus and its Prevention in Japan. Tokyo Japan: Springer; 1994.

    Book  Google Scholar 

  22. Noto H, Terao T, Ryou S, et al. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980–1994. J Gastroenterol Hepatol. 2003;18:943–9.

    Article  PubMed  Google Scholar 

  23. Koyama T, Matsuda I, Sato S, et al. Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981–1992) and epidemiological evidence for its efficacy. Hepatol Res. 2003;26:287–92.

    Article  PubMed  Google Scholar 

  24. World Health O. Weekly epidemiological record. . [full issue]. 2009;84(40):405–20.

    Google Scholar 

  25. Buster EH, Hansen BE, Lau GK, et al. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa. Gastroenterology. 2009;137:2002–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by “AMED Program on the Innovative Development and the Application of New Drugs for Hepatitis B under Grant Number JP20fk0310118, JP21fk0310118h0005 and JP22fk0310502h0001,” “The Japanese Society of Gastroenterology Grant,” and “JSPS KAKENHI Grant Number JP19K08479”.

Author information

Authors and Affiliations

Authors

Contributions

KS and KI: designed the research study and contributed to the interpretation of data and wrote the manuscript. HY, HY, YT, YK, YT, YU, KY, FI, JI, MK, TU, HT, EM, KM, TM, NY, AS, MK, YS, KM, AO, YF and MS: contributed to data collection. MM and MY: supervised the writing of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Kiyoaki Ito.

Ethics declarations

Conflict of interest

KI and MY received research funding from AbbVie, Bayer Pharma, EA pharma, Otsuka Pharmaceutical, and Sumitomo Pharmaceutical. JI received research funding from AbbVie. YT received honorariums from FUJIREBIO inc., Gilead Sciences Inc, and GlaxoSmithKline PLC. YT also received research funding from FUJIFILM Corporation, Janssen Pharmaceutical K. K., Gilead Sciences Inc, Board of Trustees of the Leland, Stanford Junior University, GlaxoSmithKline PLC., FUJIREBIO inc., Sysmex Corp. YU received honorariums from Gilead Sciences and AbbVie Inc. YU also received research funding from AbbVie Inc. MK received honorariums from Gilead Sciences, AbbVie, Chugai, Eisai, Bayer, Lilly, and Otsuka. TU received honorariums from AbbVie and also received research funding from AbbVie and Tosoh Corporation. TM received research funding from IQVIA solutions. MY received honorariums from Otsuka pharmaceutical and Sumitomo pharmaceutical.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 205 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sakamoto, K., Ito, K., Yotsuyanagi, H. et al. Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan. J Gastroenterol 57, 971–980 (2022). https://doi.org/10.1007/s00535-022-01921-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-022-01921-4

Keywords

Navigation